[Acute ischemia and heart failure during cyclic chemotherapy in a patient with plasmocytic myeloma].
作者信息
Drzewoski J, Olszańska-Skorek T, Urbańska-Ryś H, Kończalik P, Krykowski E
机构信息
Pracowni Farmakologi Klinicznej Zakładu Farmakologii AM.
出版信息
Pol Tyg Lek. 1990;45(51-52):1056-8.
PMID:2098746
Abstract
摘要
相似文献
1
[Acute ischemia and heart failure during cyclic chemotherapy in a patient with plasmocytic myeloma].[浆细胞性骨髓瘤患者周期性化疗期间的急性缺血与心力衰竭]
Pol Tyg Lek. 1990;45(51-52):1056-8.
2
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.美法仑和泼尼松联合长春新碱、卡莫司汀、美法仑、环磷酰胺及泼尼松治疗多发性骨髓瘤的比较：东部肿瘤协作组E2479研究结果
Cancer. 1997 Apr 15;79(8):1561-7.
3
[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].多发性骨髓瘤化疗后白血病前期骨髓增生异常综合征：“1例新病例”
Sangre (Barc). 1991 Oct;36(5):434-5.
4
[Pneumonia caused by Salmonella in a patient with myeloma].[一名骨髓瘤患者的沙门氏菌肺炎]
Sangre (Barc). 1995 Jun;40(3):234-5.
5
6
7
[Chemotherapy of multiple myeloma].[多发性骨髓瘤的化疗]
Sov Med. 1991(3):43-6.
8
Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Arch Immunol Ther Exp (Warsz). 1981;29(2):145-53.
9
Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
Cancer Treat Rep. 1982 Nov;66(11):1971-3.
10
[The influence of verapamil on platelet function in patients with multiple myeloma].[维拉帕米对多发性骨髓瘤患者血小板功能的影响]
Pol Merkur Lekarski. 1997 Feb;2(8):109-10.
Zotero 插件